AbbVie seeks to deepen immunology pipeline with small molecule partnership 12-Dec-2022 By Ben Hargreaves AbbVie will gain access to HotSpot’s drug discovery platform for small molecule IRF5 inhibitors for the potential treatment of autoimmune diseases.
Enosi: COVID-19 adds to autoimmune challenges 26-Oct-2020 By Jenni Spinner A leader from the drug research and development company discusses unique problems faced by COVID-19 patients with prior cancer and autoimmune diagnoses.
Astellas taps into Pandion’s platform for bispecifics development 05-Nov-2019 By Vassia Barba Astellas and Pandion join forces to develop treatments for autoimmune pancreatic diseases using the latter’s modular immune effector.
